Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

180 Life Sciences Corp (NQ: ATNF )

2.280 -0.060 (-2.56%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 107,755
Open 2.350
Bid (Size) 2.200 (10)
Ask (Size) 2.450 (3)
Prev. Close 2.340
Today's Range 2.210 - 2.450
52wk Range 1.160 - 17.75
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
180 Life Sciences Corp. Retains Senior Technology Consultant and Commences Gaming Technology Platform Integration
Via ACCESSWIRE
180 Life Sciences Corp. Appoints Mr. Jay Goodman to Board of Directors
Via ACCESSWIRE

Performance

YTD
-41.66%
-41.66%
1 Month
-54.12%
-54.12%
3 Month
+19.37%
+19.37%
6 Month
+31.03%
+31.03%
1 Year
-66.67%
-66.67%

More News

Read More
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Dow Jumps Over 100 Points; Alcoa Profit Beats Estimates
Via Benzinga
Topics Stocks
Exposures US Equities
180 Life Sciences Corp. - Corporate Updates
Via ACCESSWIRE
ATNF Stock Earnings: 180 Life Sciences Reported Results for Q2 2024
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why TSMC Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Nasdaq Moves Higher; Morgan Stanley Profit Beats Estimates
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Dow Jumps 250 Points; U.S. Bancorp Earnings Top Views
Via Benzinga
Topics Stocks
Exposures US Equities
US Stocks Mixed; Abbott Reports Better-Than-Expected Q3 Results
Via Benzinga
180 Life Sciences Corp. Interim CEO, Blair Jordan, Issues Letter to Stockholders; Provides Update on Newly Acquired Gaming Technology Platform
Via ACCESSWIRE
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Says Recent Acquisition to Help Capitalize on ‘Tremendous’ Potential in iGaming Market
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
180 Life Sciences Corp. Regains Compliance with Nasdaq's Minimum Stockholders' Equity Rule and Expands into the Global iGaming Sector
Via ACCESSWIRE
BioMedNewsBreaks — 180 Life Sciences Corp. (NASDAQ: ATNF) Provides Update on Strategic Corporate Initiatives
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
BioMedNewsBreaks — 180 Life Sciences Corp. (NASDAQ: ATNF) Appoints Omar Jimenez as Chief Financial Officer
Via Investor Brand Network
180 Life Sciences Announces the Appointment of Omar Jimenez as Chief Financial Officer
From 180 Life Sciences Corp.
Via GlobeNewswire
Why Modular Medical Shares Are Trading Higher By Around 29%; Here Are 20 Stocks Moving Premarket
Via Benzinga
BioMedNewsBreaks — 180 Life Sciences Corp. (NASDAQ: ATNF) Reports on Human Clinical Trial Evaluating Solid Formulation of CBD with Enhanced Oral Uptake
Via Investor Brand Network
180 Life Sciences Announces Positive Topline Results of a Clinical Pharmacology Study Testing a New Solid Formulation of CBD with Enhanced Oral Uptake
From 180 Life Sciences Corp.
Via GlobeNewswire
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Granted Additional Extension to Regain Compliance with Continued Nasdaq Listing Requirements
Via Investor Brand Network
180 Life Sciences Granted an Additional Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements
From 180 Life Sciences Corp.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.